Safety, immunogenicity, and immune persistence of two inactivated COVID-19 vaccines replacement vaccination in China: An observational cohort study

BACKGROUND: To mitigate a national shortage of WIBP-CorV COVID-19 vaccine, China’s regulator approved administering BBIBP-CorV after WIBP-CorV for completion of a primary series. In a pragmatic observational study, we compared immunogenicity and safety of a primary series of WIBP-CorV followed by BB...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoqi, Deng, Yao, Zhao, Li, Wang, Lei, Fu, Zhenwang, Tang, Lin, Ye, Fei, Liu, Qianqian, Wang, Wenling, Wang, Siquan, Hu, Bo, Guan, Xuhua, Han, Zhuling, Tong, Yeqing, Rodewald, Lance E., Yin, Zundong, Tan, Wenjie, Wang, Fuzhen, Huang, Baoying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393163/
https://www.ncbi.nlm.nih.gov/pubmed/36031501
http://dx.doi.org/10.1016/j.vaccine.2022.08.037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393163/
https://www.ncbi.nlm.nih.gov/pubmed/36031501
http://dx.doi.org/10.1016/j.vaccine.2022.08.037

Ejemplares similares